Selecting Appropriate Animal Models for Pain Research

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Model-Question Alignment is Paramount: Selecting an animal pain model necessitates a precise match between the research question (e.g., mechanism, target identification, analgesic efficacy) and the model's construct, face, and predictive validity, recognizing that no single model excels in all three.
• Pain Type Dictates Model Choice: Acute nociceptive models (e.g., tail flick, hot plate) are suitable for screening acute analgesics but do not capture affective pain dimensions, while inflammatory models (e.g., formalin, CFA) are relevant for conditions like arthritis, and neuropathic models (e.g., CCI, SNL) are crucial for studying nerve injury mechanisms but have imperfect clinical predictive validity.
• Outcome Measures Must Reflect Pain Dimensions: Reflexive withdrawal tests primarily assess spinal reflexes and can yield false positives from sedation; operant assays and spontaneous pain behaviors (e.g., guarding, altered gait) offer better face and motivational validity for chronic pain conditions.
• Species, Strain, Sex, and Age are Critical Variables: Rodents are prevalent due to genetic tools, but larger species may be needed for specific anatomy; inbred strains exhibit significant baseline pain differences, and sex differences in pain sensitivity and analgesic response necessitate inclusion of both sexes unless mechanistically justified.
• Welfare and Translational Validity Require Rigorous Reporting: Adherence to the 3Rs (Replacement, Reduction, Refinement) is essential, with prospective severity assessment and defined humane endpoints; transparent reporting of blinding procedures, randomization, model induction techniques, and exclusion criteria is critical for scientific validity and regulatory review.

Pain research depends on laboratory animals to model human and veterinary pain conditions, yet the translational record of these models is mixed. This article provides a decision framework for veterinary researchers selecting pain models, covering the major model categories, the behavioral and physiological endpoints used to measure pain, and the criteria that determine whether a model will answer a specific research question. The intended reader is a veterinary scientist designing a study, reviewing a protocol, or evaluating the literature for translational relevance. The article assumes familiarity with laboratory animal medicine and focuses on model selection instead of on anesthesia or analgesia protocols.

The central problem in pain model selection is that pain is a private experience. In animals, it must be inferred from behavior, physiology, or learned responses, and each inference carries assumptions about what the animal is experiencing The pain of pain: challenges of animal behavior models. A model that works for one research question may be misleading for another. A drug that suppresses a withdrawal reflex may have no effect on spontaneous pain behavior, and a model that produces robust mechanical hypersensitivity may not reproduce the neuroimmune interactions of clinical neuropathic pain. The researcher must therefore match the model to the mechanism under investigation, the pain type being studied, and the endpoint that will be measured.

Animal models offer advantages that human studies cannot provide, including control over genetic background, the ability to induce defined tissue or nerve injuries, and access to invasive recording and tissue sampling The necessity of animal models in pain research. These advantages come with obligations. Institutional animal care and use oversight, housing standards, and veterinary care requirements are defined by national and international frameworks, and the researcher must integrate model selection with these obligations from the outset Guide for the Care and Use of Laboratory Animals.

At a Glance

The Conceptual Basis of Pain Models

Pain models are built on the distinction between nociception and pain. Nociception is the neural detection of noxious stimuli, and it can be measured reliably in animals through reflex withdrawal or electrophysiological recording. Pain, as a conscious experience, cannot be measured directly. Behavioral models therefore operate on the assumption that certain measurable responses, such as guarding, licking, or reduced locomotion, reflect the aversive quality of the stimulus The pain of pain: challenges of animal behavior models. This assumption is reasonable but imperfect, and it explains why no single model is sufficient for most research programs.

The validity of a pain model is assessed on three axes. Construct validity asks whether the model reproduces the underlying pathophysiology of the clinical condition. Face validity asks whether the model looks like the condition, for example whether the animal shows spontaneous pain behavior or hypersensitivity. Predictive validity asks whether drugs that work in the clinic work in the model and whether drugs that fail in the clinic fail in the model. These axes frequently conflict. A model with excellent construct validity may be difficult to score behaviorally, while a model with excellent predictive validity for one drug class may miss other mechanisms entirely.

Acute Nociceptive Models

Acute models apply a brief noxious stimulus and measure the latency or threshold for withdrawal. Common stimuli include thermal heat applied to the tail or paw, mechanical pressure, and electrical stimulation of the paw or tail. These models are technically simple, reproducible, and suitable for screening analgesic compounds. Their limitation is that they measure reflex withdrawal, which is mediated largely at the spinal level and does not require the forebrain structures associated with the affective dimension of pain. A compound that blocks spinal reflexes may appear highly effective in an acute model while having no effect on the emotional or motivational aspects of clinical pain.

Inflammatory Models

Inflammatory pain models introduce a localized inflammatory insult, typically through injection of complete Freund's adjuvant, carrageenan, or formalin into the paw or joint. These agents produce edema, heat, and hypersensitivity that develop over hours to days and resolve over days to weeks. The formalin test is distinctive in that it produces a biphasic response, with an early neurogenic phase followed by a prolonged inflammatory phase, allowing the researcher to distinguish central and peripheral contributions within a single session. Inflammatory models have good construct validity for conditions such as arthritis, postoperative pain, and soft tissue injury, and they are widely used to evaluate nonsteroidal anti-inflammatory drugs and cyclooxygenase inhibitors.

Neuropathic Pain Models

Neuropathic pain models involve injury to the peripheral or central nervous system. Peripheral models include chronic constriction injury of the sciatic nerve, spinal nerve ligation, spared nerve injury, and partial sciatic nerve transection. Each produces a distinct pattern of afferent input and sympathetic involvement, and the choice among them depends on the mechanism under study. Central models include spinal cord injury and thalamic lesions. Neuropathic models produce long-lasting mechanical allodynia and thermal hypersensitivity, and they are the primary tools for studying mechanisms such as ectopic discharge, sodium channel upregulation, and microglial activation. Their predictive validity for clinical neuropathic pain is imperfect, and many compounds that reverse hypersensitivity in rodents have failed in human trials.

Visceral Pain Models

Visceral pain models target pain arising from internal organs, including the colon, bladder, and uterus. Common approaches include colorectal distension, intracolonic instillation of irritants such as mustard oil or capsaicin, and cyclophosphamide-induced cystitis. Visceral pain differs from somatic pain in its autonomic accompaniment, referred pain patterns, and poor localization, and these differences are reproduced in animal models. Visceral models are technically more demanding than somatic models because the stimulus is less accessible and the behavioral response is less stereotyped. They are essential for studying conditions such as irritable bowel syndrome, interstitial cystitis, and endometriosis.

Matching Model to Research Question

The selection process begins with a precise statement of the research question. If the question concerns a specific molecular pathway, the researcher should choose a model in which that pathway is known to be engaged, and should consider whether a transgenic or knockout strain is available. If the question concerns analgesic efficacy, the researcher should choose a model with established predictive validity for the drug class of interest, and should include a positive control drug to confirm that the model is working as expected.

The time course of the model must match the study design. Acute models resolve within minutes and are suitable for single-session experiments. Inflammatory models develop over hours and persist for days, allowing repeated testing but requiring attention to the trajectory of hypersensitivity. Neuropathic models persist for weeks or months, which permits longitudinal study but increases the welfare burden and the risk of attrition. The researcher should plot the expected time course of the model against the planned testing schedule before committing to a design.

Sex is a critical variable in pain research. Human and animal studies show sex differences in pain sensitivity and analgesic responses, and these differences are mediated by hormonal, genetic, and immune mechanisms. The researcher should include both sexes unless there is a mechanistic justification for studying one sex, and should report results by sex instead of pooling data that may obscure a difference. Strain choice is equally important, because inbred rodent strains differ markedly in baseline pain sensitivity and in their response to specific models.

Translational Validity and Outcome Measures

The selection of a pain model depends on the validity it offers for the specific research question. Face validity asks whether the model resembles the human or veterinary condition. Construct validity asks whether the model engages the same underlying mechanisms. Predictive validity asks whether analgesic efficacy in the model forecasts efficacy in the target species. No single model achieves all three forms of validity for every pain type, and investigators must rank which form matters most for their hypothesis.

Outcome measures determine what the model can actually tell you. Reflexive withdrawal tests, such as paw withdrawal latency to thermal stimuli or withdrawal threshold to von Frey filaments, measure spinal reflex circuits instead of the affective or cognitive components of pain. These tests are highly reproducible and technically simple, but they can produce false positives for compounds that alter motor function or sedation. Operant assays, where an animal chooses between avoiding a noxious stimulus and obtaining a reward, engage supraspinal processing and better reflect the motivational dimension of pain. Conditioned place preference and place escape avoidance paradigms add further layers of behavioral complexity.

Spontaneous pain behaviors, including guarding, grooming, and changes in gait, offer face validity that evoked measures lack. Automated home cage monitoring systems can quantify voluntary activity, burrowing, and nesting behavior over days or weeks. These measures detect ongoing pain that reflexive tests miss, but they require more equipment and longer acclimation periods. The choice between evoked and spontaneous measures should follow the clinical question. A study of acute postoperative pain may reasonably rely on evoked withdrawal thresholds. A study of chronic neuropathic pain should include spontaneous behavior as a primary outcome.

Species Selection and Anatomical Considerations

Rodents dominate pain research because of their genetic tractability, short reproductive cycles, and the availability of validated behavioral assays. Mice enable transgenic manipulation of pain-related genes, and the growing availability of Cre-recombinase lines allows cell-type specific interrogation of pain circuits. Rats offer larger tissue volumes for electrophysiology and microdialysis and are often preferred for surgical models of neuropathic pain.

Species choice changes the interpretation of results. The National Research Council guide for laboratory animal care emphasizes that housing conditions, social environment, and enrichment alter baseline pain sensitivity and analgesic responses. Group-housed rodents show different stress hormone profiles than singly housed animals, and these differences affect pain behavior. Cage enrichment changes nociceptive thresholds in some strains. Investigators must standardize husbandry across experimental groups and report housing conditions in publications.

Strain differences within a species are equally consequential. Common inbred mouse strains differ markedly in baseline thermal sensitivity and in the magnitude of mechanical allodynia after nerve injury. The same surgical procedure can produce robust hypersensitivity in one strain and minimal effect in another. Strain selection should be justified by the literature for the specific model and outcome measure, and pilot data should confirm the expected phenotype before committing to a full study.

Model-Specific Decision Points

The table below compares the principal pain model categories and the factors that should drive selection.

The formalin model deserves specific comment because it captures both acute and tonic pain in a single preparation. The first phase reflects direct chemical activation of nociceptors, while the second phase involves peripheral inflammation and central sensitization. The model is inexpensive and technically simple, but the biphasic response complicates interpretation of drug effects. A compound that suppresses only the second phase may act on central sensitization, while one that suppresses both phases may have broad analgesic or local anesthetic properties.

Sex, Age, and Comorbidity Considerations

Pain research has historically favored male animals, and this bias has distorted the translational literature. Sex differences in pain sensitivity and analgesic responses are documented across multiple species and model types. The US National Institutes of Health now requires sex as a biological variable in preclinical studies, and the NC3Rs guidance on experimental design provides practical frameworks for incorporating sex into study design without doubling animal numbers. Investigators should power studies to detect sex differences when the literature suggests they exist, or explicitly justify a single-sex design.

Age changes pain processing and analgesic pharmacology. Neonatal animals show altered nociceptive circuitry and exaggerated responses to injury. Aged animals exhibit reduced nerve regeneration capacity and altered inflammatory signaling, which changes the time course of neuropathic pain models. The choice of age should mirror the target population. A study of postoperative pain in pediatric patients requires juvenile animals, while a study of chronic pain in older adults requires aged cohorts.

Comorbid conditions further complicate model selection. Obesity alters inflammatory pain responses and drug distribution. Diabetes accelerates peripheral neuropathy and changes the phenotype of nerve injury models. Hypertension modifies pain sensitivity through angiotensin signaling. Investigators studying pain in the context of these comorbidities must select models that reproduce the comorbid state, such as streptozotocin-induced diabetes or high-fat diet induced obesity, and confirm that the comorbidity itself does not confound the pain outcome measure.

Documentation and Reporting Standards

The AVMA professional practice resources and the WOAH terrestrial animal health standards both emphasize that animal welfare and scientific validity depend on transparent reporting. The ARRIVE guidelines, while not cited directly here, provide the framework that most journals now require for preclinical studies. At minimum, publications must report the number of animals per group, the method of randomization, the blinding procedure, the exact model induction technique, the timing of outcome assessments, and the criteria for excluding animals from analysis.

Blinding is a persistent weakness in pain research. Evoked withdrawal testing requires the experimenter to observe the animal's response, and knowledge of treatment assignment biases these observations. A blinded experimenter who is unaware of group allocation should perform all behavioral testing. Automated behavioral systems reduce but do not eliminate observer bias, because the investigator still chooses which animals to include and when to test them.

The NC3Rs resources on refinement emphasize that pain models themselves cause suffering, and the severity of that suffering must be justified by the scientific value of the data. Severity assessment should be prospective, with predefined humane endpoints that trigger early euthanasia. Weight loss, failure to groom, and reduced mobility are objective indicators that apply across most models. The severity classification of a procedure should be reported in the methods section, and any unexpected mortality or morbidity should be disclosed in the results.

Equipment and Technical Infrastructure

The choice of equipment follows the outcome measure. Electronic von Frey devices provide quantitative mechanical thresholds but require calibration and consistent application force. Manual von Frey filaments are cheaper but operator-dependent. Thermal testing equipment must maintain a stable baseline temperature and deliver reproducible stimulus intensity. Gait analysis systems require specialized cameras and software, and they demand that animals walk voluntarily across a defined runway.

Surgical models of neuropathic pain require microsurgical instruments, an operating microscope or magnifying loupes, and consistent surgical technique. The spared nerve injury model requires ligation of two of the three terminal branches of the sciatic nerve. The chronic constriction injury model requires four loose ligatures around the sciatic nerve. The spinal nerve ligation model requires resection of the L5 and L6 spinal nerves. Each model has a learning curve, and surgical skill directly affects the consistency of the resulting hypersensitivity. Investigators should document their surgical success rate and exclude animals with incomplete nerve injury or excessive tissue damage.

The MSD Veterinary Manual provides species-specific guidance on anesthetic protocols and perioperative care that applies to surgical pain models. Aseptic technique, perioperative analgesia, and postoperative monitoring are mandatory components of any survival surgery. The choice of perioperative analgesic must be considered carefully, because it can interact with the pain model itself. An opioid given at the time of nerve injury may alter the development of neuropathic pain, confounding the experimental readout. Investigators must decide whether perioperative analgesia is compatible with the research question and document that decision explicitly.

Recognized Complications and Failure Modes

Pain research models fail in characteriztic patterns, and early detection depends on distinguishing model failure from genuine biological variation. The most common complication is the development of unintended tissue pathology at the implantation or injection site. A cannula that migrates, a ligature that erodes into adjacent structures, or an injected adjuvant that spreads beyond the intended compartment can convert a focal model into a systemic or multi-site condition. Daily visual inspection, palpation of the surgical site, and scheduled imaging or post-mortem verification are the minimum monitoring standard. Weight loss exceeding 15% of baseline, reduced grooming, or altered gait outside the expected post-operative window should trigger immediate model integrity assessment instead of analgesic adjustment alone.

A second failure mode is the loss of stimulus fidelity over time. Thermal and mechanical testing paradigms depend on consistent application geometry, and even small changes in paw position, floor temperature, or filament calibration shift withdrawal thresholds. Automated systems reduce but do not eliminate this problem. Regular calibration logs, blinded operators, and inter-rater reliability checks performed at intervals detect drift before it corrupts a dataset. The National Research Council guide for laboratory animal care emphasizes that environmental enrichment, social housing, and handling practices directly influence baseline pain sensitivity and must remain constant across experimental groups.

A third complication is the development of learned helplessness or conditioned responses in animals undergoing repeated testing. Animals that anticipate a noxious stimulus may display anticipatory avoidance that is mistaken for hyperalgesia. Conversely, animals habituated to handling may show artificially elevated withdrawal thresholds. Randomizing stimulus order, limiting test sessions per day, and using automated scoring where available reduce these confounds. The review of behavioral challenges in animal pain models notes that ethologically valid behaviors often conflict with the highly controlled operant paradigms favored in pharmaceutical development, and this tension must be resolved explicitly at the design stage.

Common Errors and Corrective Actions

Less experienced investigators frequently select a model based on convenience or institutional precedent instead of on the specific research question. A student studying chemotherapy-induced peripheral neuropathy who defaults to a spinal nerve ligation model because the equipment is available will generate data that cannot answer the intended question. The corrective action is to write the research question first, then map each model's mechanism of injury, time course, and behavioral readout to that question before any animal is ordered.

A second recurring error is the conflation of reflexive withdrawal with pain experience. Withdrawal latency measures spinal reflex integrity and nociceptive processing, not the affective or motivational components of pain. Investigators who report only reflexive measures and then draw conclusions about analgesic efficacy are overstating their evidence. The defense of animal models in pain research argues that complementary use of operant paradigms, conditioned place preference, and grimace scales provides a more complete picture, and that reliance on a single behavioral readout is a principal cause of translational failure.

A third error is inadequate blinding. Investigators who know the treatment assignment unconsciously influence behavioral scoring, and this bias is well documented across species. The corrective action is mandatory blinding of all outcome assessors, with code breaks permitted only after data collection is complete. A related error is the use of inappropriate statistical units, treating repeated measures from the same animal as independent observations, which inflates sample size and produces false positives.

Limitations of the Evidence Base

The translational record of animal pain models is mixed, and expert opinion still diverges on the causes. Some investigators argue that the models themselves are inadequate, while others contend that the problem lies in how outcomes are measured and interpreted. The historical review of animal pain models describes the field's evolution from purely reflexive assays toward more complex behavioral measures, but acknowledges that no single model reproduces the full human chronic pain experience. This is particularly true for conditions with prominent affective components, such as fibromyalgia or complex regional pain syndrome, where no animal model captures the full syndrome.

A second limitation is the species gap in pain neurobiology. Rodent models dominate the literature, yet rodent nociceptive pathways, drug metabolism, and behavioral repertoires differ from those of larger mammals and humans. The MSD Veterinary Manual provides species-specific guidance on pain recognition and assessment that underscores these differences, and investigators working in non-rodent species must often adapt validated rodent protocols without equivalent validation data. Where the evidence base is thin, the responsible approach is to state the limitation explicitly in the methods and to interpret results with corresponding caution.

Referral, Consultation, and Reporting

Veterinarians engaged in pain research should consult a laboratory animal veterinarian whenever a model produces unexpected morbidity, when analgesic interventions appear ineffective, or when humane endpoints are approached. The AVMA professional practice resources provide guidance on euthanasia criteria and pain management that applies to research settings. Institutional animal care and use committees require prompt reporting of unanticipated pain or distress, and the NC3Rs resources on refinement offer practical frameworks for reducing severity and improving welfare outcomes.

Regulatory reporting obligations vary by jurisdiction and funding source. Investigators should know whether their institution requires reporting of adverse events to the funding agency, the animal welfare oversight body, or both. The WOAH terrestrial animal health standards apply primarily to production animals and disease surveillance, but investigators working with livestock models should verify whether their protocol triggers reporting under those standards. When a model repeatedly fails to induce the expected phenotype, consultation with a statistician and a senior pain researcher is warranted before abandoning the model or modifying the protocol, since both decisions carry implications for data integrity and animal use.

Frequently Asked Questions

How do I choose a pain model when my budget or equipment is limited?

Prioritize the research question over the model's sophistication. Thermal withdrawal latency tests require only a hot plate or radiant heat source and are reliable for acute nociceptive screening. Mechanical allodynia testing with von Frey filaments is inexpensive and widely used for neuropathic and inflammatory work. When automated video tracking or gait analysis is unavailable, manual scoring of spontaneous behaviors, such as paw guarding or burrowing, remains valid if observers are blinded and inter-rater reliability is established. The National Center for the Replacement, Refinement and Reduction of Animals in Research provides practical guidance on refining behavioral assays without costly infrastructure. Consider whether a less resource-intensive model can answer the mechanistic question before committing to complex surgical or genetic preparations.

What should I do when the ideal species for my pain model is not available at my institution?

Re-evaluate whether the species-specific feature you require is essential to the hypothesis. If you need a particular anatomical structure, such as the temporomandibular joint, a rodent model may still capture the relevant inflammatory or neuropathic mechanisms. If a larger animal is required for imaging or surgical access, rabbits or sheep may serve as alternatives to dogs or nonhuman primates, depending on the pain type under study. Consult the Guide for the Care and Use of Laboratory Animals for species-specific housing and procedural requirements before changing your plan. Discuss the substitution with a veterinary anesthesiologist or laboratory animal clinician early, as behavioral endpoints validated in one species may not transfer directly to another.

How do I document pain model procedures and outcomes for regulatory review and publication?

Maintain a prospective record that includes the model induction method, anesthetic and analgesic details, postoperative monitoring schedule, humane endpoints, and the timing and method of behavioral testing. Record the number of animals excluded and the reasons for exclusion. For each behavioral assay, state the observer blinding status, the testing environment, and the specific outcome measure, such as withdrawal threshold or latency. The AVMA professional practice resources and the Guide for the Care and Use of Laboratory Animals outline expectations for animal care documentation. Journals increasingly require reporting checklists that specify model details, randomization, and statistical methods, so prepare these documents concurrently with data collection instead of retrospectively.

How do I explain the choice of a pain model to an institutional animal care and use committee or a funding reviewer?

Frame the justification around the scientific question and the translational target. State which pain type, such as inflammatory or neuropathic, the model represents and cite the clinical condition it models. Explain why the chosen species and induction method are appropriate, and describe the specific outcome measures and their validation. Acknowledge the model's limitations, including any known failures to predict clinical efficacy, as discussed in reviews of challenges in animal behavior models of pain. Address the 3Rs directly by explaining why replacement is not feasible, how animal numbers were minimized through power analysis, and which refinements reduce distress. Reviewers respond well to a concise table linking each model component to a published source.

Can I use the same pain model for both mechanistic studies and analgesic efficacy screening?

Yes, but the endpoints and validation requirements differ. For mechanistic work, you may prioritize molecular or electrophysiological readouts alongside behavior. For efficacy screening, the model must demonstrate sensitivity to established analgesics with known clinical profiles, and you should include a positive control group. A model validated for one purpose does not automatically serve the other. For example, a neuropathic model that reliably shows tactile allodynia may not detect centrally acting analgesics if the outcome measure lacks appropriate dynamic range. The defense of animal models in pain research emphasizes that translational relevance depends on matching the model and outcome measure to the specific analgesic mechanism under investigation.

How do I respond when a client or referring veterinarian asks whether animal pain research is justified?

Explain that animal models remain necessary for understanding pain mechanisms and for developing analgesics that cannot be tested ethically in humans. The rationale for the necessity of animal models in pain research rests on the ability to control genetic background, induce specific pathologies, and perform invasive recordings. Emphasize that oversight bodies require justification of animal numbers, refinement of procedures, and consideration of replacement alternatives, as outlined in NC3Rs guidance. Acknowledge that models have limitations and that translational failures have occurred, but note that these failures have driven methodological improvements. Frame the work as one component of a broader strategy that includes human imaging, genetic studies, and clinical trials.

Related Clinical & Scientific Guides

• Refining IACUC Protocols to Minimize Animal Pain and Distress
• Health Monitoring Programs for Laboratory Animal Facilities
• Anesthetic Risk Assessment in Laboratory Animals: Preoperative Evaluation

References and Further Reading

• Animal models in pain research.. 1997.
• The necessity of animal models in pain research.. 2010.
• The pain of pain: challenges of animal behavior models.. 2015.
• Guide for the Care and Use of Laboratory Animals, 8th Edition. National Academies Press, 2011.
• NC3Rs Resources on Replacement, Reduction and Refinement. NC3Rs.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Selecting Animal Models for Neurological Research
• Selecting Animal Models for Infectious Disease Research
• Animal Model Selection for Neurological Research
• Scoring Severity of Procedures in Animal Research Protocols
• Applying the 3Rs in Veterinary Research: Practical Examples

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.